Pioneering the Next Generation of RNA Medicines

The Nucleic Acid Therapeutics Initiative (NATi), hosted by the Agency for Science, Technology and Research (A*STAR), is Singapore’s national platform dedicated to advancing RNA-based medicines and revolutionising drug and vaccine development.
Vision

Build Singapore into a globally competitive hub & model of excellence for NAT research, clinical translation and commercialisation

Mission

Lead the discovery-to-early clinical development and initiating the commercialisation of high-value NAT

Build preparedness and resilience against future pandemics via integration of nucleic acid biomanufacturing technology capabilities

Catalyse the growth of Singapore life sciences ecosystem via successful creation of new Biotechs

Strategy

Translational platform

that invests and stewards public research funding to grow SG biotech ecosystem

Accelerator

for building and integrating key capabilities across SG ecosystem to develop & commercialise RNA assets while strengthening national resilience

Nexus

to connect RNA researchers & clinicians, with industry and VC partners